Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 225.72M | 250.42M | 202.84M | 172.58M | 225.76M |
Gross Profit | 139.12M | 51.77M | 59.66M | 24.08M | 74.64M |
EBITDA | -1.43M | 50.58M | 36.06M | 41.49M | 42.61M |
Net Income | -18.61M | 3.97M | -4.89M | 3.81M | -2.88M |
Balance Sheet | |||||
Total Assets | 134.05M | 133.39M | 116.52M | 129.82M | 119.77M |
Cash, Cash Equivalents and Short-Term Investments | 29.10M | 46.93M | 28.82M | 48.44M | 48.48M |
Total Debt | 79.02M | 61.23M | 60.53M | 63.75M | 58.27M |
Total Liabilities | 105.95M | 86.68M | 73.77M | 82.18M | 75.94M |
Stockholders Equity | 28.10M | 46.71M | 42.74M | 47.64M | 43.83M |
Cash Flow | |||||
Free Cash Flow | 24.25M | 57.87M | 20.34M | 31.23M | 38.43M |
Operating Cash Flow | 30.35M | 62.69M | 26.91M | 33.88M | 41.80M |
Investing Cash Flow | -6.06M | -4.82M | -6.56M | -2.64M | -2.90M |
Financing Cash Flow | -40.06M | -41.82M | -37.92M | -33.31M | -56.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$155.68M | 30.22 | 4.12% | 74.82% | -17.13% | -51.35% | |
60 Neutral | HK$41.00M | 10.79 | 20.64% | ― | 70.92% | ― | |
56 Neutral | HK$25.22B | 4.10 | -2.03% | 6.15% | -0.31% | -67.64% | |
52 Neutral | HK$38.00M | ― | -88.20% | ― | -2.31% | -910.00% | |
52 Neutral | HK$55.75M | ― | -19.60% | 6.58% | -22.98% | -285.25% | |
50 Neutral | HK$45.23M | ― | -202.81% | ― | -55.08% | -316.18% | |
39 Underperform | HK$41.64M | ― | -146.45% | ― | -24.83% | -6.70% |